Functional capillary rarefaction in mild blood pressure elevation

Clinical and Translational Science

Volumn 1, Issue 1, 2008, Pages 75-79

  Cheng, Cynthia ^a   Diamond, James J ^a   Falkner, Bonita ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAPILLAROSCOPY; CAPILLARY DENSITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ETHNIC DIFFERENCE; FEMALE; HUMAN; HYPEREMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RACE DIFFERENCE; SYSTOLIC BLOOD PRESSURE; VASCULAR FRAGILITY; VASODILATATION; BLACK PERSON; BLOOD PRESSURE; CAPILLARY; CAUCASIAN; ETHNIC GROUP; MICROSCOPY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; VASCULAR ENDOTHELIUM;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CAPILLARIES; ENDOTHELIUM, VASCULAR; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; MALE; MICROSCOPY; MIDDLE AGED; RISK FACTORS; VASODILATION;

EID: 77953371556     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2008.00016.x     Document Type: Article

References (25)

1. Kannel WB, Higgins M. Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens Suppl. 1990; 8: S3-S8.
2. Feihl F, Liaudet L, Waeber B, Levy BI. Hypertension: A disease of the microcirculation? Hypertension. 2006; 48: 1012-1017.
3. Cohn JN. Is it the blood pressure or the blood vessel? JASH. 2007; 1: 5-16.
4. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: A new target for treatment? Circulation. 2001; 104: 735-740.
5. Pladys P, Sennlaub F, Brault S, Checchin D, Lahaie I, Lê NL, Bibeau K, Cambonie G, Abran D, Brochu M, Thibault G, Hardy P, Chemtob S, Nuyt AM. Microvascular rarefaction and decreased angiogenesis in rats with fetal programming of hypertension associated with exposure to a low protein diet in utero. Am J Physiol Regul Integr Comp Physiol. 2005; 289: R1580-R1588.
6. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest. 1997; 99: 1873-1879.
7. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension. 1999; 34(4 Pt 1): 655-658.
8. Antonios TF, Rattray FM, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart. 2003; 89: 175-178.
9. Debbabi H, Uzan L, Mourad JJ, Safar M, Levy BI, Tibirica E. Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens. 2006; 19: 477-483.
10. Serne EH, Gans RO, ter Maaten JC, Tangelder GJ, Donker AJ, Stehouwer CD. Impaired skin capillary recruitment in essential high blood pressure is caused by both perfused and structural capillary rarefaction. Hypertension. 2001; 38: 238-242.
11. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension. 1999; 33: 998-1001.
12. Gasser P, Buhler FR. Nailfold microcirculation in normotensive and essential hypertensive subjects, as assessed by video-microscopy. J Hypertens. 1992; 10: 83-86.
13. Schram MT, Schalkwijk CG, Bootsma AH, Fuller JH, Chaturvedi N, Stehouwer CD. EURODIAB Prospective Complications Study Group. Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res. 2005; 37 (Suppl 1): 49-55.
14. JNC 7 Express: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Publication No. 03-5233, National Institutes of Health, Washington, DC: 2003.
15. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. New Engl J Med. 2001; 345: 1291-1297.
16. Sivertsson R. The hemodynamic importance of structural vascular changes in essential hypertension. Acta Physiol Scand Suppl. 1970; 343: 1-56.
17. Raitakari OT, Celermajer DS. Testing for endothelial dysfunction. Ann Med. 2000; 32: 293-304.
18. Pasimeni G, Ribaudo MC, Capoccia D, Rossi F, Bertone C, Leonetti F, Santiemma V. Non-invasive evaluation of endothelial dysfunction in uncomplicated obesity: Relationship with insulin resistance. Microvasc Res. 2006; 71: 115-120.
19. Tousoulis D, Antoniades C, Stefanadis C. Evaluating endothelial function in humans: A guide to invasive and non-invasive techniques. Heart. 2005; 91: 553-558.
20. Lind L, Sarabi M, Millgard J. Methodological aspects of the evaluation of endothelium-dependent vasodilatation in the human forearm. Clin Physiol. 1998; 18: 81-87.
21. Prewitt RL, Chen II, Dowell R. Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol. 1982; 243: H243-H251.
22. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to high blood pressure in non-hypertensive participants in the Framingham Heart Study: A cohort study. Lancet. 2001; 358: 1682-1686.
23. Serné EH, Stehouwer CD, ter Maaten JC, ter Wee PM, Rauwerda JA, Donker AJ, Gans RO. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation. 1999; 99: 896-902.
24. Schulte KL, Braun J, Meyer-Sabellek W, Wegscheider K, Gotzen R, Distler A. Functional versus structural changes of forearm vascular resistance in hypertension. Hypertension. 1988; 11: 320-325.
25. Carpentier PH. New techniques for clinical assessment of the peripheral microcirculation. Drugs. 1999; 59 Spec: 17-22.